Impact of the Clinical Trials Act 2018 on clinical trial activity in Japan from 2018 to 2020: a retrospective database study using new and conventional Japanese registries
Objective To clarify the impact of Japan’s Clinical Trials Act (CTA), which was enacted in April 2018, on subsequent clinical trial activity through an analysis of Japanese registry data.Design Retrospective database study.Setting We extracted information on clinical intervention studies registered...
Saved in:
| Main Authors: | Hiroyuki Taruno, Mari S Oba, Osamu Takizawa, Kayoko Kikuchi, Kazuaki Matsui, Mayumi Shikano |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-07-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/7/e059092.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical data required for the approval of pediatric pharmaceuticals in Japan
by: Hisamitsu Haigo, et al.
Published: (2025-04-01) -
The Challenge of Rising China for Japan in the Context of Normalization of Sino-Japanese Relations in 2014-2018
by: Y. V. Leksyutina
Published: (2019-12-01) -
Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry
by: Peng Xu, et al.
Published: (2020-01-01) -
Changing landscape of geriatric clinical trials: Analysis of Clinical Trials Registry of India
by: Abissha Sargunaraj, et al.
Published: (2024-10-01) -
Principal investigators’ experience of COVID-19 therapeutic clinical trials in Japan: a qualitative study
by: Tatsuo Iiyama, et al.
Published: (2025-07-01)